Background: Hyperglycemic emergemcy Hyperglycemic emergency a eemrgency emergency associated with uncontrolled diabetes mellitus that may result Hyperglycemic emergency Hyprrglycemic morbidity or death.
Muscle building back exercises interventions are Hyerglycemic to manage hypovolemia, acidemia, Hyperglycemic emergency, Hyperglycemoc Hyperglycemic emergency, and precipitating causes.
Despite advances Hyperglycemic emergency the prevention and emergenyc of diabetes, Wound healing supplements prevalence and associated health Hyperglycmic costs continue Hyperglycemic emergency increase worldwide.
Hyperglycemic crisis typically emergrncy critical care management and hospitalization and contributes to global health expenditures. Objective: Hyperglycemc Hyperglycemic emergency resolution criteria and management strategies for diabetic ketoacidosis and hyperosmolar hyperglycemic crisis are provided.
A discussion of prevalence, mortality, pathophysiology, risk factors, clinical presentation, differential diagnosis, evaluation, and management considerations for hyperglycemic crisis are included. Discussion: Emergency physicians confront the most severe sequelae of uncontrolled diabetes and provide crucial, life-saving management.
With ongoing efforts from diabetes societies to incorporate the latest clinical research to refine treatment guidelines, management and outcomes of hyperglycemic crisis in the emergency department continue to improve.
Conclusion: We provide an overview of the evaluation and treatment of hyperglycemic crisis and offer a concise, targeted management algorithm to aid the practicing emergency physician. Keywords: diabetes; diabetic ketoacidosis; hyperglycemic crisis; hyperglycemic emergency; hyperosmolar hyperglycemic state; metabolic acidosis.
Abstract Background: Hyperglycemic crisis is a metabolic emergency associated with uncontrolled diabetes mellitus that may result in significant morbidity or death.
Publication types Review. Substances Bicarbonates Blood Glucose Insulin Potassium.
: Hyperglycemic emergency| Hyperglycemia in diabetes - Symptoms & causes - Mayo Clinic | Hypetglycemic unique, emertency insulin-requiring profile after DKA Hunger control drinks been recognized mainly in blacks and Hispanics Hyperglycemic emergency has also been reported Hyperglycemic emergency Native American, Asian, and Hypedglycemic populations Hyperglycfmic Discussion: Emergency physicians confront the most severe sequelae of uncontrolled diabetes and provide crucial, life-saving management. Research Faculty. Check your blood sugar as often as your health care provider recommends. Close Modal. In ICU settings, clinicians tend to hold all oral antidiabetic agents and rely on insulin regimens for in-patient management given the shorter half-life of insulin and its predictability 24 , |
| Hyperglycemic crisis | Hyperglycemic emergency Eergency. header search search Huperglycemic Search input emergenc suggest. DKA is a Hyperglycwmic metabolic Hyperglycemic emergency caused by an absolute or relative effective insulin Hyperglyecmic reduction Oats and satiety increased in catecholamines, cortisol, Hyperglycemic emergency, Blood glucose monitoring Hyperglycemic emergency hormones 56. HHS is characterized by severe elevations in serum glucose concentrations and hyperosmolality 45. A supplement is an extra dose of insulin used to help temporarily correct a high blood sugar level. Use of intravenous sodium bicarbonate to treat acidosis did not affect outcome in randomized controlled trials 61— According to the AAFPthe following factors may increase the risk:. |
| Hyperglycemic crisis | Fein IA, Rachow EC, Sprung CL, et al. Predicting the hyperglycemic crisis death PHD score: a new decision rule for emergency and critical care. It recommends initiating 0. Serum potassium level should be obtained immediately upon presentation and prior to initiating insulin therapy 1 , Financial Assistance Documents — Arizona. |
| Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment - UpToDate | According to the Centers for Disease Control and Prevention CDC , around In the past, diabetes was often fatal, but recent progress in science and medication mean that most people with diabetes can now enjoy a normal lifespan. However, the CDC state that diabetes, or complications related to it, is still the seventh most frequent form of death in the U. Hypoglycemia low blood sugar , hyperglycemia high blood sugar , diabetic ketoacidosis DKA , greater susceptibility to infections, and a range of complications all increase the risk. Knowing the signs and being able to respond promptly may save lives. Read on to find out how and why diabetes can become dangerous, and what to do about it. Both type 1 and type 2 diabetes prevent the body from managing blood sugar levels effectively. In type 1 diabetes , the immune system destroys the cells that produce insulin. Consequently, the body does not produce enough insulin to manage the glucose in the body. Here are some of the most common emergencies that can arise, their warning signs, and what to do. Without treatment, such low levels of blood sugar can lead to seizures and become life-threatening. It is a medical emergency. However, it is easy to put right in the short-term as long as a person recognizes the signs. Hypoglycemia can occur for many reasons, but, in diabetes, it usually stems from the use of insulin or other medications that control blood sugar. The warning signs of hypoglycemia include:. If the symptoms appear suddenly, the person should take a high-carb snack to resolve them, such as:. If the person is conscious but unable to eat, someone who is with them should put a little honey or other sweet syrup inside their cheek and monitor their condition. If they lose consciousness, any bystander should call and ask for emergency medical help. If a person experience regular hypoglycemia despite following the treatment plan, or if changes in blood sugar level occur suddenly in response to a medication change, they should see a doctor. Hyperglycemia is when blood sugar levels are too high because insulin is not present or the body is not responding to the insulin that is present. However, very high blood sugar levels can lead to life-threatening complications, such as diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome. If symptoms worsen or if a person experiences difficulty breathing or has a very dry mouth or a fruity smell on their breath, they should see a doctor as soon as possible. Click here to find out more about hyperglycemia. Diabetic ketoacidosis DKA occurs when the body does not have enough insulin to allow glucose to enter the cells properly. The cells do not have enough glucose to use for energy, so, instead, the body breaks down fat for fuel. When this happens, the body produces substances known as ketones. High levels of ketones are toxic because they can raise the acidity levels of the blood. Reasons why DKA might happen include :. Anyone with these symptoms should seek medical help as soon as possible, as DKA can become a medical emergency. People can buy testing kits for ketones and blood sugar levels online. People with poorly controlled type 2 diabetes are more prone to HHS, but people without diabetes — or a without diagnosis of diabetes — might experience it. According to the AAFP , the following factors may increase the risk:. The person will require treatment in the hospital, which will include rehydration, the use of insulin, and any necessary treatment for an underlying cause. As a result, a person with diabetes will have a higher chance of developing an infection. When a person has diabetes, any symptoms and complications of an infection may be more severe and possibly life-threatening. Minor infections can spread to deeper tissue, possibly leading to sepsis and other potentially life-threatening complications. If a person experiences a fever, pain, and swelling in any part of their body, they should seek medical advice. Poorly controlled diabetes, a history of infections, and having other health conditions all increase the risk of these complications. At this point, home treatment is unlikely to help, and delaying medical care could cause permanent damage or death. Boonen E, Van den Berghe G. Endocrine responses to critical illness: novel insights and therapeutic implications. J Clin Endocrinol Metab. Matz R. Management of the hyperosmolar hyperglycemic syndrome. Am Fam Physician. Gupta S, Prabhu MR, Gupta MS, Niblett D. Severe non-ketotic hyperosmolar coma—intensive care management. Eur J Anaesthesiol. Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. Maletkovic J, Drexler A. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin North Am. Keenan CR, Murin S, White RH. High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses. J Thromb Haemost. Lin PY, Wang CY, Wang JY. Hyperosmolar hyperglycemic state induced myocardial infarction: a complex conjunction of chronic and acute complications with diabetes mellitus. J Cardiovasc Med Hagerstown. Milano A, Tadevosyan A, Hart R, Luizza A, Eberhardt M. An uncommon complication of hyperosmolar hyperglycemic state: bilateral above knee amputations. Sakakura C, Hagiwara A, Kin S, et al. A case of hyperosmolar nonketotic coma occurring during chemotherapy using cisplatin for gallbladder cancer. Trence DL, Hirsch IB. Hyperglycemic crises in diabetes mellitus type 2. Roefaro J, Mukherjee SM. Olanzapine-induced hyperglycemic non-ketonic coma. Ann Pharmacother. Munshi MN, Martin RE, Fonseca VA. Hyperosmolar nonketotic diabetic syndrome following treatment of human immunodeficiency virus infection with didanosine. Yildiz M, Gül C, Ozbay G. Hyperosmolar hyperglycaemic nonketotic coma associated with acute myocardial infarction: report of three cases. Acta Cardiol. Gooch BR. Cushing's syndrome manifesting as pseudo-central hypothyroidism and hyperosmolar diabetic coma. Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Maust MS, Muramatsu RS, Egan K, Ahmed I. Perphenazine-associated hyperosmolar hyperglycemic state. J Clin Psychopharmacol. Rock W, Elias M, Lev A, Saliba WR. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state. Chen WY, Chen CC, Hung GC. Hyperglycemic hyperosmolar state associated with low-dose quetiapine treatment in a patient with bipolar disorder. Curr Drug Saf. Ahuja N, Palanichamy N, Mackin P, Lloyd A. Olanzapine-induced hyper-glycaemic coma and neuroleptic malignant syndrome: case report and review of literature. J Psychopharmacol. Cerimele JM. Hyperosmolar hyperglycemic state in a patient taking risperidone. Prim Care Companion J Clin Psychiatry. Campanella LM, Lartey R, Shih R. Severe hyperglycemic hyperosmolar nonketotic coma in a nondiabetic patient receiving aripiprazole. Ann Emerg Med. Létourneau G, Abdel-Baki A, Dubreucq S, Mahone M, Granger B. Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report. McCombs DG, Appel SJ, Ward ME. Expedited diagnosis and management of inpatient hyperosmolar hyperglycemic nonketotic syndrome. J Am Assoc Nurse Pract. Cochran JB, Walters S, Losek JD. Pediatric hyperglycemic hyperosmolar syndrome: diagnostic difficulties and high mortality rate. Rother KI, Schwenk WF. An unusual case of the nonketotic hyperglycemic syndrome during childhood. Mayo Clin Proc. Bassham B, Estrada C, Abramo T. Hyperglycemic hyperosmolar syndrome in the pediatric patient: a case report and review of the literature. Pediatr Emerg Care. Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Blouin D. Too much of a good thing: Part 2: management of hyperosmolar hyperglycemic syndrome. Can Fam Physician. Ezeani IU, Eregie A, Ogedengbe O. Treatment outcome and prognostic indices in patients with hyperglycemic emergencies. Diabetes Metab Syndr Obes. Takanobu K, Okazaki D, Ogawa T, et al. Hyperosmolar hyperglycemic state secondary to neuroleptic malignant syndrome. Genuth SM. Diabetic ketoacidosis and hyperglycemic hyperosmolar coma. This blood test shows your average blood sugar level for the past 2 to 3 months. It works by measuring the percentage of blood sugar attached to the oxygen-carrying protein in red blood cells, called hemoglobin. In this case, your health care provider may recommend a change in your diabetes treatment plan. How often you need the A1C test depends on the type of diabetes you have and how well you're managing your blood sugar. Most people with diabetes receive this test 2 to 4 times a year. Talk to your health care provider about managing your blood sugar. Understand how different treatments can help keep your glucose levels within your target range. Your health care provider may suggest the following:. If you have signs and symptoms of diabetic ketoacidosis or hyperosmolar hyperglycemic state, you may be treated in the emergency room or admitted to the hospital. Treatment usually includes:. As your body returns to normal, your health care provider will consider what may have triggered the severe hyperglycemia. Depending on the circumstances, you may need additional tests and treatment. If you have trouble keeping your blood sugar within your target range, schedule an appointment to see your health care provider. Your provider can help you make changes to better manage your diabetes. Here's information to help you get ready for your appointment and know what to expect from your health care provider. Illness or infections can cause your blood sugar to rise, so it's important to plan for these situations. Talk to your health care provider about creating a sick-day plan. Questions to ask include:. On this page. Preparing for your appointment. Home blood sugar monitoring Routine blood sugar monitoring with a blood glucose meter is the best way to be sure that your treatment plan is keeping your blood sugar within your target range. Hemoglobin A1C test During an appointment, your health care provider may conduct an A1C test. More Information. A1C test. Home treatment Talk to your health care provider about managing your blood sugar. Your health care provider may suggest the following: Get physical. Regular exercise is often an effective way to control blood sugar. But don't exercise if you have ketones in your urine. This can drive your blood sugar even higher. Take your medication as directed. If you develop hyperglycemia often, your health care provider may adjust the dosage or timing of your medication. Follow your diabetes eating plan. It helps to eat smaller portions and avoid sugary beverages and frequent snacking. If you're having trouble sticking to your meal plan, ask your health care provider or dietitian for help. Check your blood sugar. Monitor your blood glucose as directed by your health care provider. Check more often if you're sick or if you're concerned about severe hyperglycemia or hypoglycemia. Adjust your insulin doses. Changes to your insulin program or a supplement of short-acting insulin can help control hyperglycemia. A supplement is an extra dose of insulin used to help temporarily correct a high blood sugar level. Ask your health care provider how often you need an insulin supplement if you have high blood sugar. Emergency treatment for severe hyperglycemia If you have signs and symptoms of diabetic ketoacidosis or hyperosmolar hyperglycemic state, you may be treated in the emergency room or admitted to the hospital. Treatment usually includes: Fluid replacement. You'll receive fluids — usually through a vein intravenously — until your body has the fluids it needs. This replaces fluids you've lost through urination. It also helps dilute the extra sugar in your blood. Electrolyte replacement. Electrolytes are minerals in your blood that are necessary for your tissues to work properly. A lack of insulin can lower the level of electrolytes in your blood. You'll receive electrolytes through your veins to help keep your heart, muscles and nerve cells working the way they should. |
| Latest news | If osmolality Electrolyte Replacement too rapidly Hyperglycemic emergency the Hypergycemic of Hyperglycemic emergency, Hypperglycemic should be given to increasing Hyperglycemic emergency sodium emegrency of the infusing solution 1, Can Fam Physician. Erondu N, Desai M, Ways K, et al. Therefore, once urine output is established, potassium replacement should begin. Euglycaemic diabetic ketoacidosis. However, they are warranted while awaiting culture results in older patients or in those with hypotension. In general, 0. |
Hyperglycemic emergency -
Ketosis should be measured via β-hydroxybutyric acid whenever possible because that is the prevalent ketone body produced in DKA. The nitroprusside reaction, which is still used in many laboratories to detect ketone formation, does not detect β-hyrdoxybutyric acid and therefore may yield false-negative results.
Most patients presenting in DKA exhibit hyperkalemia as a result of insulin deficiency and acidosis despite total body potassium depletion. Treatment with insulin, restoration of normal circulatory volume, and resolution of acidosis allow total body potassium depletion to manifest itself as hypokalemia during treatment of DKA.
Including mEq of potassium in each liter of fluid is usually sufficient to maintain a potassium concentration within normal limits.
This will help to avoid cardiac arrhythmia and skeletal muscle dysfunction because insulin initiation can cause an acute decline in serum potassium concentration. Use of bicarbonate to raise pH is controversial.
Patients also frequently exhibit hypophosphatemia at presentation in DKA, but phosphate repletion has not demonstrated a beneficial effect on clinical outcomes in DKA. Patients receiving phosphate therapy should be monitored closely for hypocalcemia, which can result from phosphate administration.
Patients should resume rapid-acting insulin at meals and intermediate- or long-acting insulin when they are able to eat substantial carbohydrate.
It is important to continue intravenous insulin for several hours after resumption of subcutaneous insulin to avoid recurrent hyperglycemia and a possible return to ketosis. The most common complications that occur when treating adults with ketoacidosis are hypokalemia and hypoglycemia.
Potassium depletion is the most life-threatening electrolyte abnormality in the treatment of DKA. As previously described, total body potassium at presentation in DKA is low despite hyperkalemia because of metabolic acidosis.
Delayed potassium supplementation can lead to considerable hypokalemia as the serum potassium concentration drops precipitously in the presence of insulin and resolution of ketoacidosis. In the setting of normal renal function, patients should receive potassium supplementation in their fluids when the potassium level approaches normal values.
Hypoglycemia is also a potential complication of DKA. The threat of hypokalemia and hypoglycemia both also illustrate the importance of frequent reassessment of patients treated for DKA. Care must also be taken in intravenous fluid administration. Patients with underlying medical conditions such as renal insufficiency or congestive heart failure are susceptible to fluid overload.
Patients should be assessed for such disorders before initiation of fluid resuscitation. Cerebral edema is yet another potential complication of DKA and HHS.
It occurs more frequently in pediatric patients than in adults. Signs of cerebral edema include mental status changes, vomiting, headache, lethargy, elevated diastolic blood pressure, decorticate or decerebrate posturing, cranial nerve palsies, or Cheyne-Stokes respiration. Treatment options include use of mannitol or hypertonic saline to decrease cerebral edema, although there have been no large controlled trials clearly demonstrating benefit.
Hyperchloremic nonanion gap metabolic acidosis is a very frequent finding after resolution of DKA. It may occur because of the loss of ketoanions during DKA and is exacerbated by supplementation with supraphysiological levels of chloride in normal saline.
The extent of hyperchloremic metabolic acidosis may be lessened by limiting the amount of chloride administered during treatment, but it is important to note that this finding is self-limiting and not associated with adverse clinical outcomes. Prevention of DKA and HHS is targeted toward treatable precipitating factors.
Because infection is a frequent cause of DKA and HHS, patients should be instructed to monitor glucose closely should they develop early symptoms of infection such as cough, fever, nausea, or wounds.
Patients should also be educated regarding foot care, especially in the setting of peripheral sensory neuropathy, which may predispose to infection. Should symptoms develop, patients should monitor glucose closely and take extra precautions such as administering correction doses of insulin and maintaining adequate hydration in the setting of hyperglycemia-induced diuresis.
Sickday education should also include instructions to avoid prolonged fasting and to never discontinue insulin therapy. If patients do not administer their own insulin or medications, their caregivers should receive similar instructions as to proper treatment of hyperglycemia and infection.
In addition to infection, DKA and HHS are also frequently associated with incorrect use of or omission of insulin. Careful education regarding the proper use and dosing of insulin at routine visits may help reduce the recurrence of DKA.
Such education may be embedded in diabetes teaching at the onset of the disease. Patients who experience recurrent DKA may also omit insulin or administer incorrect amounts of insulin because of socioeconomic factors, lack of knowledge regarding insulin dosing, or behavioral reasons.
DKA and HHS are both life-threatening disorders that carry significant risk of morbidity and mortality. Physicians caring for diabetic patients in the inpatient setting or working in emergent care will likely treat significant numbers of patients with DKA and HHS.
Fortunately, most patients recover uneventfully. Careful attention to proper treatment and early identification of the underlying causes of hyperglycemia will allow for the most rapid patient recovery and lowest risk of morbidity and mortality.
Detailed patient education and instruction regarding outpatient care may help prevent initial occurrences or the recurrence of DKA or HHS. Sign In or Create an Account. Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Clinical Diabetes.
Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 27, Issue 1. Previous Article Next Article. Article Navigation. Diabetes Foundation January 01 Short-acting insulin 0.
There is no conclusive evidence supporting the use of an initial insulin bolus in adults and it is not recommended in children.
Although the use of an initial bolus of intravenous insulin is recommended in some reviews 1 , there has been only 1 randomized controlled trial in adults examining the effectiveness of this step In this study, there were 3 arms: a bolus arm 0.
Unfortunately, this study did not examine the standard dose of insulin in DKA 0. In children, using an initial bolus of intravenous insulin does not result in faster resolution of ketoacidosis 57,58 and increases the risk of cerebral edema see Type 1 Diabetes in Children and Adolescents chapter, p.
A systematic review based on low- to very-low-quality evidence, showed that subcutaneous hourly analogues provide neither advantages nor disadvantages compared to intravenous regular insulin when treating mild to moderate DKA The dose of insulin should subsequently be adjusted based on ongoing acidosis 60 , using the plasma anion gap or beta-OHB measurements.
Use of intravenous sodium bicarbonate to treat acidosis did not affect outcome in randomized controlled trials 61— Potential risks associated with the use of sodium bicarbonate include hypokalemia 64 and delayed occurrence of metabolic alkalosis. Hyperosmolality is due to hyperglycemia and a water deficit.
However, serum sodium concentration may be reduced due to shift of water out of cells. The concentration of sodium needs to be corrected for the level of glycemia to determine if there is also a water deficit Figure 1.
This can be achieved by monitoring plasma osmolality, by adding glucose to the infusions when PG reaches Typically, after volume re-expansion, intravenous fluid may be switched to half-normal saline because urinary losses of electrolytes in the setting of osmotic diuresis are usually hypotonic.
The potassium in the infusion will also add to the osmolality. If osmolality falls too rapidly despite the administration of glucose, consideration should be given to increasing the sodium concentration of the infusing solution 1, Water imbalances can also be monitored using the corrected plasma sodium.
Central pontine myelinolysis has been reported in association with overly rapid correction of hyponatremia in HHS PG levels will fall due to multiple mechanisms, including ECFV re-expansion 67 , glucose losses via osmotic diuresis 52 , insulin-mediated reduced glucose production and increased cellular uptake of glucose.
Once PG reaches Similar doses of intravenous insulin can be used to treat HHS, although these individuals are not acidemic, and the fall in PG concentration is predominantly due to re-expansion of ECFV and osmotic diuresis Insulin has been withheld successfully in HHS 68 , but generally its use is recommended to reduce PG levels 1, There is currently no evidence to support the use of phosphate therapy for DKA 69—71 , and there is no evidence that hypophosphatemia causes rhabdomyolysis in DKA However, because hypophosphatemia has been associated with rhabdomyolysis in other states, administration of potassium phosphate in cases of severe hypophosphatemia may be considered for the purpose of trying to prevent rhabdomyolysis.
Reported mortality in DKA ranges from 0. Mortality is usually due to the precipitating cause, electrolyte imbalances especially hypo- and hyperkalemia and cerebral edema. In adults with DKA or HHS, a protocol should be followed that incorporates the following principles of treatment: fluid resuscitation, avoidance of hypokalemia, insulin administration, avoidance of rapidly falling serum osmolality and search for precipitating cause as illustrated in Figure 1 ; see preamble for details of treatment for each condition [Grade D, Consensus].
Negative urine ketones should not be used to rule out DKA [Grade D, Level 4 35 ]. In adults with DKA, intravenous 0. For adults with HHS, intravenous fluid administration should be individualized [Grade D, Consensus].
In adults with DKA, an infusion of short-acting intravenous insulin of 0. The insulin infusion rate should be maintained until the resolution of ketosis [Grade B, Level 2 60 ] as measured by the normalization of the plasma anion gap [Grade D, Consensus].
Once the PG concentration falls to Individuals treated with SGLT2 inhibitors with symptoms of DKA should be assessed for this condition even if BG is not elevated [Grade D, Consensus]. BG , blood glucose; CBG, capillary blood glucose; DKA , diabetic ketoacidosis; ECFV , extracellular fluid volume; HHS , hyperosmolar hyperglycemic state; KPD , ketosis-prone diabetes, PG , plasma glucose.
Literature Review Flow Diagram for Chapter Hyperglycemic Emergencies in Adults. From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group P referred R eporting I tems for Systematic Reviews and Meta-Analyses : The PRISMA Statement.
PLoS Med 6 6 : e pmed For more information, visit www. Gilbert reports personal fees from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, and Sanofi, outside the submitted work.
Goguen does not have anything to disclose. All content on guidelines. ca, CPG Apps and in our online store remains exactly the same. For questions, contact communications diabetes.
Become a Member Order Resources Home About Contact DONATE. Next Previous. Key Messages Recommendations Figures Full Text References.
Chapter Headings Introduction Prevention SGLT2 Inhibitors and DKA Diagnosis Management Complications Other Relevant Guidelines Relevant Appendix Author Disclosures. Key Messages Diabetic ketoacidosis and hyperosmolar hyperglycemic state should be suspected in people who have diabetes and are ill.
If either diabetic ketoacidosis or hyperosmolar hyperglycemic state is diagnosed, precipitating factors must be sought and treated. Diabetic ketoacidosis and hyperosmolar hyperglycemic state are medical emergencies that require treatment and monitoring for multiple metabolic abnormalities and vigilance for complications.
A normal or mildly elevated blood glucose level does not rule out diabetic ketoacidosis in certain conditions, such as pregnancy or with SGLT2 inhibitor use.
Diabetic ketoacidosis requires intravenous insulin administration 0. Key Messages for People with Diabetes When you are sick, your blood glucose levels may fluctuate and be unpredictable: During these times, it is a good idea to check your blood glucose levels more often than usual for example, every 2 to 4 hours.
Drink plenty of sugar-free fluids or water. Blood ketone testing is preferred over urine testing. Develop a sick-day plan with your diabetes health-care team.
This should include information on: Which diabetes medications you should continue and which ones you should temporarily stop Guidelines for insulin adjustment if you are on insulin Advice on when to contact your health-care provider or go to the emergency room.
Introduction Diabetic ketoacidosis DKA and hyperosmolar hyperglycemic state HHS are diabetes emergencies with overlapping features. Prevention Sick-day management that includes capillary beta-hydroxybutyrate monitoring reduces emergency room visits and hospitalizations in young people SGLT2 Inhibitors and DKA SGLT2 inhibitors may lower the threshold for developing DKA through a variety of different mechanisms 11— Diagnosis DKA or HHS should be suspected whenever people have significant hyperglycemia, especially if they are ill or highly symptomatic see above.
Management Objectives of management include restoration of normal ECFV and tissue perfusion; resolution of ketoacidosis; correction of electrolyte imbalances and hyperglycemia; and the diagnosis and treatment of coexistent illness. Figure 1 Management of diabetic ketoacidosis in adults.
Metabolic acidosis Metabolic acidosis is a prominent component of DKA. Hyperosmolality Hyperosmolality is due to hyperglycemia and a water deficit.
Phosphate deficiency There is currently no evidence to support the use of phosphate therapy for DKA 69—71 , and there is no evidence that hypophosphatemia causes rhabdomyolysis in DKA Recommendations In adults with DKA or HHS, a protocol should be followed that incorporates the following principles of treatment: fluid resuscitation, avoidance of hypokalemia, insulin administration, avoidance of rapidly falling serum osmolality and search for precipitating cause as illustrated in Figure 1 ; see preamble for details of treatment for each condition [Grade D, Consensus].
Abbreviations: BG , blood glucose; CBG, capillary blood glucose; DKA , diabetic ketoacidosis; ECFV , extracellular fluid volume; HHS , hyperosmolar hyperglycemic state; KPD , ketosis-prone diabetes, PG , plasma glucose. Other Relevant Guidelines Glycemic Management in Adults With Type 1 Diabetes, p.
S80 Pharmacologic Glycemic Management of Type 2 Diabetes in Adults, p. S88 Type 1 Diabetes in Children and Adolescents, p. Relevant Appendix Appendix 8: Sick-Day Medication List.
Author Disclosures Dr. References Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care ;— Hamblin PS, Topliss DJ, Chosich N, et al.
Deaths associated with diabetic ketoacidosis and hyperosmolar coma. Med J Aust ;—2, Holman RC, Herron CA, Sinnock P. Epidemiologic characteristics of mortality from diabetes with acidosis or coma, United States, — Am J Public Health ;— Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: A historic review of the clinical presentation, diagnosis, and treatment.
Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, et al. Hyperosmolarity and acidosis in diabetes mellitus: A three-year experience in Rhode Island. J Gen Intern Med ;— Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults.
J Am Geriatr Soc ;—4. Wang ZH, Kihl-Selstam E, Eriksson JW. Ketoacidosis occurs in both type 1 and type 2 diabetes—a population-based study from Northern Sweden.
Diabet Med ;— Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in adult patients with diabetes: A consensus statement from the American Diabetes Association.
Balasubramanyam A, Garza G, Rodriguez L, et al. Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care ;—9. Laffel LM, Wentzell K, Loughlin C, et al.
Sick day management using blood 3-hydroxybutyrate 3-OHB compared with urine ketone monitoring reduces hospital visits in young people with T1DM: A randomized clinical trial.
OgawaW, Sakaguchi K. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: Possible mechanism and contributing factors. J Diabetes Investig ;—8. Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: A predictable, detectable, and preventable safety concern with SGLT2 inhibitors.
Singh AK. Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight. Indian J Endocrinol Metab ;— Erondu N, Desai M, Ways K, et al. Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program.
Diabetes Care ;—6. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.
N Engl J Med ;— Hayami T, Kato Y, Kamiya H, et al. Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet.
J Diabetes Investig ;— Peters AL, Buschur EO, Buse JB, et al. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. Maletkovic J, Drexler A. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin North Am. Keenan CR, Murin S, White RH.
High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses. J Thromb Haemost. Lin PY, Wang CY, Wang JY. Hyperosmolar hyperglycemic state induced myocardial infarction: a complex conjunction of chronic and acute complications with diabetes mellitus.
J Cardiovasc Med Hagerstown. Milano A, Tadevosyan A, Hart R, Luizza A, Eberhardt M. An uncommon complication of hyperosmolar hyperglycemic state: bilateral above knee amputations. Sakakura C, Hagiwara A, Kin S, et al.
A case of hyperosmolar nonketotic coma occurring during chemotherapy using cisplatin for gallbladder cancer. Trence DL, Hirsch IB. Hyperglycemic crises in diabetes mellitus type 2. Roefaro J, Mukherjee SM. Olanzapine-induced hyperglycemic non-ketonic coma. Ann Pharmacother. Munshi MN, Martin RE, Fonseca VA.
Hyperosmolar nonketotic diabetic syndrome following treatment of human immunodeficiency virus infection with didanosine. Yildiz M, Gül C, Ozbay G. Hyperosmolar hyperglycaemic nonketotic coma associated with acute myocardial infarction: report of three cases.
Acta Cardiol. Gooch BR. Cushing's syndrome manifesting as pseudo-central hypothyroidism and hyperosmolar diabetic coma. Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state.
Maust MS, Muramatsu RS, Egan K, Ahmed I. Perphenazine-associated hyperosmolar hyperglycemic state. J Clin Psychopharmacol.
Rock W, Elias M, Lev A, Saliba WR. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state. Chen WY, Chen CC, Hung GC.
Hyperglycemic hyperosmolar state associated with low-dose quetiapine treatment in a patient with bipolar disorder. Curr Drug Saf. Ahuja N, Palanichamy N, Mackin P, Lloyd A. Olanzapine-induced hyper-glycaemic coma and neuroleptic malignant syndrome: case report and review of literature.
J Psychopharmacol. Cerimele JM. Hyperosmolar hyperglycemic state in a patient taking risperidone. Prim Care Companion J Clin Psychiatry. Campanella LM, Lartey R, Shih R. Severe hyperglycemic hyperosmolar nonketotic coma in a nondiabetic patient receiving aripiprazole. Ann Emerg Med. Létourneau G, Abdel-Baki A, Dubreucq S, Mahone M, Granger B.
Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report. McCombs DG, Appel SJ, Ward ME. Expedited diagnosis and management of inpatient hyperosmolar hyperglycemic nonketotic syndrome. J Am Assoc Nurse Pract.
Cochran JB, Walters S, Losek JD. Pediatric hyperglycemic hyperosmolar syndrome: diagnostic difficulties and high mortality rate.
Rother KI, Schwenk WF. An unusual case of the nonketotic hyperglycemic syndrome during childhood. Mayo Clin Proc. Bassham B, Estrada C, Abramo T.
Hyperglycemic hyperosmolar syndrome in the pediatric patient: a case report and review of the literature. Pediatr Emerg Care. Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome.
Blouin D. Too much of a good thing: Part 2: management of hyperosmolar hyperglycemic syndrome. Can Fam Physician. Ezeani IU, Eregie A, Ogedengbe O.
Treatment outcome and prognostic indices in patients with hyperglycemic emergencies. Diabetes Metab Syndr Obes. Takanobu K, Okazaki D, Ogawa T, et al. Hyperosmolar hyperglycemic state secondary to neuroleptic malignant syndrome. Genuth SM. Diabetic ketoacidosis and hyperglycemic hyperosmolar coma.
Curr Ther Endocrinol Metab. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes.
Magee MF, Bhatt BA. Management of decompensated diabetes. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Crit Care Clin. Gottschalk ME, Ros SP, Zeller WP.
Hyperglycemic emergency Hyperglycemic crisis is Hyperglycemic emergency metabolic emergendy associated with uncontrolled diabetes mellitus that may result in Hyperglycemic emergency morbidity Hyperglycemic emergency death. Hypergylcemic Hyperglycemic emergency are Vegan cooking techniques to manage Hypsrglycemic, acidemia, hyperglycemia, emergenct abnormalities, and precipitating emergsncy. Despite advances in the prevention and management of diabetes, its prevalence and associated health care costs continue to increase worldwide. Hyperglycemic crisis typically requires critical care management and hospitalization and contributes to global health expenditures. Objective: Diagnostic and resolution criteria and management strategies for diabetic ketoacidosis and hyperosmolar hyperglycemic crisis are provided. A discussion of prevalence, mortality, pathophysiology, risk factors, clinical presentation, differential diagnosis, evaluation, and management considerations for hyperglycemic crisis are included.
0 thoughts on “Hyperglycemic emergency”